These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 8633252

  • 1. CPT-11 in the treatment of colorectal cancer: clinical efficacy and safety profile.
    Rougier P, Bugat R.
    Semin Oncol; 1996 Feb; 23(1 Suppl 3):34-41. PubMed ID: 8633252
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of CPT-11 (irinotecan) as a single agent in metastatic colorectal cancer.
    Shimada Y, Rougier P, Pitot H.
    Eur J Cancer; 1996 Feb; 32A Suppl 3():S13-7. PubMed ID: 8943660
    [Abstract] [Full Text] [Related]

  • 8. US pivotal studies of irinotecan in colorectal carcinoma.
    Pitot HC.
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):48-53. PubMed ID: 9726091
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CPT-11 (irinotecan) in the treatment of colorectal cancer.
    Armand JP, Ducreux M, Mahjoubi M, Abigerges D, Bugat R, Chabot G, Herait P, de Forni M, Rougier P.
    Eur J Cancer; 1995 Aug; 31A(7-8):1283-7. PubMed ID: 7577037
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
    Wiseman LR, Markham A.
    Drugs; 1996 Oct; 52(4):606-23. PubMed ID: 8891470
    [Abstract] [Full Text] [Related]

  • 13. Irinotecan hydrochloride: drug profile and nursing implications of a topoisomerase I inhibitor in patients with advanced colorectal cancer.
    Berg D.
    Oncol Nurs Forum; 1998 Apr; 25(3):535-43. PubMed ID: 9568608
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Weekly irinotecan (CPT-11) in 5-FU heavily pretreated and poor-performance-status patients with advanced colorectal cancer.
    Benavides M, García-Alfonso P, Cobo M, Muñoz-Martín A, Gil-Calle S, Carabantes F, Villar E, Graupera J, Balcells M, Pérez-Manga G.
    Med Oncol; 2004 Apr; 21(3):255-62. PubMed ID: 15456953
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CPT-11: clinical experience in phase I studies.
    Armand JP.
    Semin Oncol; 1996 Feb; 23(1 Suppl 3):27-33. PubMed ID: 8633250
    [Abstract] [Full Text] [Related]

  • 18. [[Irinotecan--experience with second-line treatment in advanced colorectal cancer] ].
    Kristó K, Izsó J, Balatoni G, Lohinszky J, Farczádi E, Szántó J, Kofi AP, Pintér T.
    Orv Hetil; 2000 Aug 13; 141(33):1817-20. PubMed ID: 10979311
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.